Tumor type: Oral Squamous Cell Carcinoma
Purpose of Study: The purpose of this study is to identify the activity of toceranib phosphate (Palladia) alone or as a radiation sensitizing agent in the treatment of feline oral squamous cell carcinoma. Inclusion Criteria:
- Have histologically or cytologically confirmed diagnosis of oral SCC
- Have a life expectancy of at least 6 weeks
- Have no evidence of metastatic disease at the time of enrollment
- Have no other serious health problems that are incompatible with the study (as renal, cardiac or hepatic insufficiency)
For more information, click here.